Business Description
Pharma Mar SA
ISIN : ES0169501022
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.43 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -58.09 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 4.86 | |||||
Beneish M-Score | -2.3 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.7 | |||||
3-Year EBITDA Growth Rate | -69 | |||||
3-Year EPS without NRI Growth Rate | -82.5 | |||||
3-Year Book Growth Rate | 24.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.23 | |||||
9-Day RSI | 69.95 | |||||
14-Day RSI | 66.81 | |||||
6-1 Month Momentum % | 17.41 | |||||
12-1 Month Momentum % | 5.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.55 | |||||
Quick Ratio | 2.01 | |||||
Cash Ratio | 1.54 | |||||
Days Inventory | 1399.57 | |||||
Days Sales Outstanding | 64.39 | |||||
Days Payable | 984.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.53 | |||||
3-Year Dividend Growth Rate | 10.6 | |||||
Forward Dividend Yield % | 1.53 | |||||
5-Year Yield-on-Cost % | 1.56 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 3.93 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93.42 | |||||
Operating Margin % | -6.2 | |||||
Net Margin % | -1.11 | |||||
FCF Margin % | -18.72 | |||||
ROE % | -0.89 | |||||
ROA % | -0.52 | |||||
ROIC % | -1.8 | |||||
3-Year ROIIC % | 3735.27 | |||||
ROC (Joel Greenblatt) % | -11.72 | |||||
ROCE % | -2.7 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 30.71 | |||||
PS Ratio | 4.68 | |||||
PB Ratio | 4.08 | |||||
Price-to-Tangible-Book | 4.19 | |||||
EV-to-EBIT | -93.52 | |||||
EV-to-EBITDA | -932.44 | |||||
EV-to-Revenue | 3.98 | |||||
EV-to-FCF | -21.46 | |||||
Price-to-Projected-FCF | 1.26 | |||||
Price-to-Median-PS-Value | 1.13 | |||||
Price-to-Net-Current-Asset-Value | 8.54 | |||||
Earnings Yield (Greenblatt) % | -1.07 | |||||
FCF Yield % | -4.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharma Mar SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 158.802 | ||
EPS (TTM) (€) | -0.1 | ||
Beta | 1.54 | ||
Volatility % | 53.03 | ||
14-Day RSI | 66.81 | ||
14-Day ATR (€) | 0.634271 | ||
20-Day SMA (€) | 39.913 | ||
12-1 Month Momentum % | 5.68 | ||
52-Week Range (€) | 26.06 - 43.9 | ||
Shares Outstanding (Mil) | 17.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharma Mar SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharma Mar SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Pharma Mar SA Frequently Asked Questions
What is Pharma Mar SA(FRA:PMRA)'s stock price today?
When is next earnings date of Pharma Mar SA(FRA:PMRA)?
Does Pharma Mar SA(FRA:PMRA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |